Package 0338-9581-02

{"route": ["INTRAVENOUS"], "spl_id": "a4227051-225f-49e2-9e5c-653ea0f99739", "openfda": {"upc": ["5413765812286"], "unii": ["82F2G7BL4E"], "rxcui": ["1790115"], "spl_set_id": ["b24afa8c-636b-4ace-99d5-51f445ad3123"], "manufacturer_name": ["Baxter Healthcare Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (0338-9581-02)  / 10 mL in 1 VIAL, SINGLE-USE (0338-9581-01)", "package_ndc": "0338-9581-02", "marketing_start_date": "20231219"}], "brand_name": "doxorubicin hydrochloride, Liposomal", "product_id": "0338-9581_a4227051-225f-49e2-9e5c-653ea0f99739", "dosage_form": "INJECTION, SUSPENSION, LIPOSOMAL", "pharm_class": ["Anthracycline Topoisomerase Inhibitor [EPC]", "Anthracyclines [CS]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "0338-9581", "generic_name": "doxorubicin hydrochloride", "labeler_name": "Baxter Healthcare Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "doxorubicin hydrochloride, Liposomal", "active_ingredients": [{"name": "DOXORUBICIN HYDROCHLORIDE", "strength": "2 mg/mL"}], "marketing_category": "UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE", "marketing_start_date": "20231219", "listing_expiration_date": "20261231"}